In our study, 58.8, 29.4 and 11.8% in ALK positive lung adenocarcinomas (N = 17) were found PD-L1 expression tiered via cutoffs of < 1, 1–49% and > =50% tumor cells (P > 0.05). The gene discussed is ALK; the disease is lung adenocarcinoma.